Headquartered in Andover, Massachusetts, TransMedics is a privately held
medical device company founded in 1998 to address the unmet need for better,
more effective organ transplant technologies. The Company has developed the
first and only system that allows a new type of organ transplant, called a
living organ transplant.
This breakthrough, investigational technology, called an Organ Care
System, is designed to maintain organs in a warm functioning state outside
of the body during transport from organ donor to recipient. The goal of
TransMedics' technology is to improve outcomes and increase organ
availability for the growing population of patients with end-stage organ
failure in need of a transplant, reduce recovery time, hospital stays and
reliance on ongoing medical therapies, and ultimately bridge the
ever-widening gap between the number of organs approved for donation and the
number of recipients awaiting transplants.